The activity-regulated cytoskeletal protein Arc (also known as Arg3.1) is required for long-term memory formation and synaptic plasticity. Arc expression is robustly induced by activity, and Arc protein localizes to both active synapses and the nucleus. Whereas its synaptic function has been examined, it is not clear why or how Arc is localized to the nucleus. We found that murine Arc nuclear expression is regulated by synaptic activity in vivo and in vitro. We identified distinct regions of Arc that control its localization, including a nuclear localization signal, a nuclear retention domain and a nuclear export signal. Arc localization to the nucleus promotes an activity-induced increase in the expression of promyelocytic leukemia nuclear bodies, which decreases GluA1 (also called Gria1) transcription and synaptic strength. We further show that Arc nuclear localization regulates homeostatic plasticity. Thus, Arc mediates the homeostatic response to increased activity by translocating to the nucleus, increasing promyelocytic leukemia protein expression and decreasing GluA1 transcription, ultimately downscaling synaptic strength.
a r t I C l e S The molecular basis of learning and memory is the modification of neuronal synapses in response to electrical activity, a process termed synaptic plasticity. The activity-regulated cytoskeletal protein Arc is crucial for long-term memory formation and essentially every form of plasticity, including long-term potentiation (LTP) 1,2 , longterm depression (LTD) 3, 4 and homeostatic scaling 5, 6 . In Arc knockout (Arc −/− ) mice, short-term learning is not affected, but consolidation and maintenance of memory are lost 7 .
Arc is extremely highly regulated. Arc is an immediate-early gene, and basal expression of its mRNA and protein are low in neurons 8, 9 . Excitatory activity regulates Arc transcription [9] [10] [11] , mRNA localization 12, 13 , translation 14, 15 and protein degradation 16 . Considerable work has focused on the localization of Arc mRNA to the synapse, but it is unknown whether activity independently regulates Arc protein localization. Arc protein is found at the synapse 17, 18 but is even more highly localized to the nucleus 19 , and nothing is known about the mechanisms controlling Arc nuclear localization.
At the synapse, Arc regulates synaptic strength in several ways. It regulates spine number and type 20 and decreases synaptic strength by promoting the internalization of AMPA receptors (AMPARs) 21, 22 . Such mechanisms may explain the involvement of Arc in synapsespecific forms of plasticity (for example, LTP and LTD) 4 . However, they cannot explain as easily how Arc mediates the cell-wide changes in homeostatic plasticity that require regulation of total amounts of AMPAR subunits, such as GluA1 (ref. 23 ). In addition, it is unclear how Arc switches from mediating responses to short-term stimuli that result in LTP and LTD to mediating responses to long-term changes in activity that result in homeostatic scaling.
Although nothing is known about how Arc nuclear localization affects synaptic plasticity, Arc may be important in the nucleus. It promotes the formation of promyelocytic leukemia tumor suppressor protein nuclear bodies (PML-NBs) 19 . These protein complexes are present in most mammalian cell nuclei and regulate nuclear functions such as transcription 24, 25 . They are found in the brain, are required for neural development 26 and associate with dysfunctional proteins in neurodegenerative diseases [27] [28] [29] [30] . However, whether or how they function in neurons is not clear.
Here we examined Arc nuclear expression in vitro and in vivo and identified stimuli and domains that control its nuclear localization. In the nucleus, Arc regulates synaptic strength and GluA1 transcription through an activity-induced increase in the number of PML-NBs to promote downscaling of synaptic strength.
RESULTS
Arc is expressed in the nucleus after novel environment We first determined whether Arc is expressed in the nucleus in vivo after a physiological stimulus. Because proteins are synthesized in the cytoplasm and must translocate to the nucleus, we induced Arc expression by exposing mice to a novel environment for varying times. We then stained mouse brains sections for Arc with a highly specific antibody (Supplementary Fig. 1a ) and the nuclear marker Hoechst. To quantify the expression of Arc, we calculated the ratio of nuclear to cytoplasmic Arc expression in the hippocampus and somatosensory cortex.
All regions showed a time-dependent increase in Arc localization to the nucleus. Under basal conditions, few cells expressed Arc. Those that did were in the dentate gyrus and expressed Arc in a r t I C l e S both the nucleus and cytoplasm. The number of neurons expressing Arc increased rapidly after exposure to the novel environment ( Supplementary Fig. 1b ). After 30 min of novel environment exposure, Arc was located primarily in the cytoplasm in all hippocampal regions. Nuclear expression was present by 2 h and increased over time. By 8 h, more Arc was in the nuclei than elsewhere in the cells (Fig. 1a-c and Supplementary Fig. 1c-e ). In the dentate gyrus, the increase in Arc expression was gradual over 0.5-8 h, whereas in CA3 and CA1, nuclear expression was increased at 2 h but then increased no further until 8 h ( Supplementary Fig. 1f-h) . In addition, we examined the somatosensory cortex. We did not detect Arc expression until 2 h, and its localization was considerably more heterogeneous ( Supplementary Fig. 1i-k) . However, Arc still showed a time-dependent increase in nuclear localization, similarly to the hippocampus.
Two domains in Arc increase nuclear localization
Although Arc is small enough to diffuse into the nucleus, the timedependent concentration of Arc in nuclei suggests that Arc nuclear localization is a regulated process. Using the program PSORT, we determined that Arc had a possible Pat7 nuclear localization signal (NLS) at amino acids 331-335. We deleted this region from GFPtagged Arc (GFP-Arc ∆Pat7 ) and found that GFP-Arc ∆Pat7 was located predominantly in the cytoplasm ( Fig. 2a and Supplementary 2a) , indicating that the Pat7 is required for nuclear localization. Deletion of the Pat7 from untagged Arc resulted in subtler decreases in nuclear localization ( Supplementary Fig. 2b-f ) that were measurable by the more sensitive quantification of the nuclear-to-cytoplasmic ratio. Without the GFP tag, Arc is smaller and may diffuse into the nucleus. We mutated several of the potentially important amino acids in the Pat7 region. A single amino acid mutation of the first proline of the Pat7 (Arc-Pat7m1) similarly decreased Arc localization to the nucleus, whereas mutations of other basic amino acids in the Pat7 (Arc-Pat7m4 and Arc-Pat7m5) did not ( Supplementary Fig. 2d ).
As an alternative approach, we used deletional analysis to find additional regulatory regions in Arc. We added a Myc epitope tag to Arc to assay subcellular distribution without substantially increasing its size. The first 77 amino acids of Arc (Myc-Arc 1-77 ) were expressed throughout the cell, as may be expected for a small protein. However, deletion of the N terminus of Arc (Myc-Arc 77-396 ) decreased Arc localization in the nucleus (Fig. 2b,c) . We then made a series of smaller deletions within the N terminus of Arc abutting the boundaries of the coiled-coil domain. Each of the deletions between amino acids 29 and 68 depleted Arc from the nucleus (Fig. 2d,e ), despite the presence of the Pat7 NLS.
To learn whether either Pat7 or the N-terminal region was sufficient to promote nuclear localization, we put them each into a heterologous protein, GFP-tagged β-galactosidase (GFP-β-gal) ( Supplementary  Fig. 2g,h) . GFP-β-gal is too large to diffuse into the nucleus and provides a stringent test of NLS function. GFP-Pat7-β-gal was expressed in nuclei considerably more than GFP-β-gal and to the same degree as GFP-Arc-β-gal, indicating that the Pat7 NLS is sufficient to actively target Arc to the nucleus. However, the N-terminal region was not a bona fide NLS because it did not target GFP-β-gal to the nucleus.
Arc contains an NES
How can a region (Arc 29-78 ) be required for nuclear localization without functioning as an NLS? We hypothesized that it causes Arc to be retained in the nucleus and that Arc also contains a nuclear export signal (NES) to return it to the cytoplasm in the absence of the retention sequence. To determine whether Arc functions as a nuclear retention domain (NRD), we inserted it into a fusion protein that shuttles into and out of the nucleus (GFP-NLS-NES). The NES dominates over an NLS, so the GFP is predominantly cytoplasmic. When we replaced the NLS with Arc 29-78 (GFP-Arc 29-78 -NES), some of the fusion protein was expressed in the nucleus, despite the strong NES, suggesting that it diffused into the nucleus and became bound ( Supplementary Fig. 3b,c) . We used fluorescence recovery after photobleaching (FRAP) to measure the effect of this region on the mobility of Arc. GFP-Arc had a lower mobile fraction than GFP alone, and that of GFP-Arc 29-78 -NES was lower still ( Supplementary  Fig. 3d-f ). Diffusion of GFP through the bleach region is so rapid that over the brief period of bleaching, a degree of equilibration between the bleach region and the rest of the cell occurs, resulting in bleaching of the entire cell, which is taken into account in the equation measuring mobility. These data show the N-terminal region decreases mobility and retains GFP in the nucleus, probably by binding to one or more nuclear constituents.
The reasoning that led to the discovery of the NRD also predicts that Arc contains an NES. We used leptomycin B to inhibit active export of proteins from the nucleus. Leptomycin B treatment for 2 h increased the ratio of nuclear to cytoplasmic Arc (Fig. 3a,b and Supplementary Fig. 3a ). This suggests that Arc is actively exported npg a r t I C l e S from nuclei, though only slowly because of the NRD. The response of Arc to leptomycin B was lost with either of two deletions between amino acids 121 and 154 ( Fig. 3a,b ), indicating this region contains an NES. We tested whether the region is sufficient to mediate active export by fusing Arc 121-154 to GFP. Arc 121-154 decreased the nuclear localization of GFP, and leptomycin B treatment reversed this effect ( Fig. 3c,d) . Arc therefore has at least three regions that control its localization to the nucleus: a Pat7 NLS, an N-terminal NRD and an NES at amino acids 121-154 ( Supplementary Fig. 3g ).
Arc nuclear localization is regulated by activity
The intricate mechanisms controlling Arc subcellular localization in vitro and in vivo suggest that Arc translocation to the nucleus is regulated by extracellular stimuli. To test this, we expressed Arc constitutively to provide a system to assay the effects of stimuli on Arc localization without confounding effects on Arc expression. We treated neurons with BDNF, which is used extensively as a model for physiologically relevant synaptic stimulation 8, [31] [32] [33] . Although neurons varied in their Arc localization ( Fig. 4 and Supplementary  Fig. 4a ), short-term BDNF treatment markedly decreased both the ratio of nuclear to cytoplasmic Arc expression ( Fig. 4a,c and Supplementary Fig. 4a -c) and the absolute amounts of Arc in the nucleus (Supplementary Fig. 4c ). Longer BDNF treatments had the opposite effect: Arc began to return to the nucleus within 2 h of BDNF stimulation. By 8 h, the ratio of nuclear to cytoplasmic Arc was increased well over baseline (Fig. 4a,c) .
To ensure the effects were not an artifact of overexpression, we examined the few neurons that express endogenous Arc under basal conditions, as well as the effect of BDNF on endogenous Arc. The temporal pattern of endogenous Arc localization was consistent with that of ectopic Arc (Fig. 4b,d ), and both were remarkably similar to the in vivo localization observed in response to a novel environment. In addition, we found the same effect with BDNF treatment of neurons transfected with GFP-tagged Arc ( Supplementary  Fig. 4e,f) , indicating that the effect is not an artifact of antibody staining. To determine whether this effect occurs with other manipulations of activity, we used bicuculline, a GABA A receptor antagonist that increases activity. Similarly to BDNF, bicuculline initially decreased and then strongly increased nuclear localization of both ectopic and endogenous Arc ( Fig. 4e-h) . Thus, ectopic Arc expression in vitro is a relevant model system to study Arc localization, and Arc localization to the nucleus is bi-directionally regulated by increased activity. npg a r t I C l e S We hypothesized that the bi-directional changes in Arc localization depend on the active import and export of Arc across the nuclear membrane. To test this, we investigated whether BDNF or bicuculline causes rapid nuclear extrusion of versions of Arc that lack the NES. Arc ∆121-140 did not show the 30-min decrease in Arc nuclear localization but did show the increase at 8 h ( Fig. 4i and Supplementary Fig. 4g ). In addition, leptomycin B inhibited the 30-min decrease in Arc nuclear localization ( Supplementary Fig. 4i ), confirming that active export is required for this effect. Conversely, Arc that lacks the NLS (Arc ∆Pat7 ) showed the 30-min decrease but did not have a significant increase in Arc nuclear localization at 8 h ( Fig. 4j and Supplementary Fig. 4h ). In addition, we used FRAP to confirm that long-term BDNF treatment increases Arc transport into the nucleus. We bleached the nucleus of GFP-Arc-transfected neurons and used the rate of recovery of GFP fluorescence as a measurement of Arc transport into the nucleus. In neurons treated with BDNF for at least 4 h, Arc returned to the nucleus faster than in untreated neurons ( Supplementary Fig. 4j ). We then examined whether continuous activity was required for Arc translocation to the nucleus. We treated neurons with continuous periods of bicuculline stimulation or 30 min of bicuculline, followed by washout and subsequent tetrodotoxin treatment until fixation at 8 h after initial treatment to ensure no lasting increase in activity. We found that continuous activity was required for increased Arc localization to the nucleus (Supplementary Fig. 4k ). Thus, short periods of increased activity result in the active export of Arc from the nucleus, and long periods of increased activity result in active import of Arc into the nucleus.
To better understand the mechanisms that control Arc localization, we examined the signaling pathways downstream of BDNF to determine which are necessary for regulating Arc nuclear import and export. We inhibited each of the three pathways downstream of BDNF with two inhibitors and then treated neurons with BDNF for either 30 min or 8 h. We found that different signaling pathways control Arc localization in response to short or long BDNF stimulation. Inhibiting the mTOR pathway blocked the export of Arc from the nucleus in response to a short BDNF stimulation but did not affect the response to a long BDNF stimulation. Conversely, inhibition of the MEK-ERK or PLC pathway blocked the import of Arc into the nucleus in response to a long BDNF treatment but did not affect BDNF-induced export (Fig. 4k,l and Supplementary Fig. 4l,m) . These data demonstrate that Arc protein localization is directly regulated by activity. In addition, the existence of three cis-acting elements within Arc and the identification of stimuli that use those domains to regulate Arc localization suggest that Arc has important and distinct functions in the nucleus.
Arc in to the nucleus regulates synaptic strength
Arc expression leads to reduced synaptic strength, an effect that was attributed to its actions at the synapse 21, 22 . That Arc localization to npg a r t I C l e S the nucleus is governed by synaptic activity raises the possibility that Arc acts in the nucleus to regulate the response to synaptic strength. Arc decreases surface expression of the AMPAR subunit GluA1 (Fig. 5a ) 21 . However, we found that versions of Arc that are expressed in the cytoplasm and not in the nucleus (Arc ∆29-38 , Arc ∆59-68 or deletion of the coiled-coil domain in the NRD, Arc ∆CC ) do not significantly decrease surface GluA1 expression ( Fig. 5b) . We used deletions in the NRD instead of deletion of the Pat7 NLS because NRD deletions have much more potent effects on untagged forms of Arc (Fig. 2) . These findings suggest that Arc functions in the nucleus to regulate surface GluA1 expression.
To ensure that this result is not due to off-target effects of deleting regions of the protein, we took a complementary approach. We made a version of Arc that was excluded from the nucleus by appending an extremely strong 14-amino-acid NES to Arc (Arc-NES). To control for the additional amino acids, we made three amino acid substitutions in the NES (Arc-mNES) that prevent its export function and result in a subcellular distribution identical to that of endogenous Arc (Fig. 5c) . Expressing the version of Arc with the same localization as endogenous Arc (Arc-mNES) resulted in the typical decrease in GluA1 surface expression. However, excluding Arc from the nucleus (by using Arc-NES) significantly impaired its ability to reduce surface GluA1 expression ( Fig. 5d) . The effects of manipulating Arc expression in the nucleus cannot be due to unintended changes in Arc expression elsewhere in the cell, as all Arc constructs had equivalent expression outside the nucleus (Supplementary Fig. 5a-d ) and localized similarly within dendrites, as demonstrated by equivalent colocalization to a synaptic marker, PSD-95 ( Supplementary  Fig. 5e,f) . In addition, all constructs also functioned similarly outside of the nucleus in regulating the endocytosis of AMPARs as measured by a GluA1 internalization assay (Supplementary Fig. 5g ).
Having shown that nuclear Arc regulates surface GluA1 expression, we next wanted to know whether these changes had consequences for AMPAR function at the synapse. We recorded mini excitatory postsynaptic currents (mEPSCs) mediated by AMPARs. Arc expression decreased mEPSC amplitude with no significant effect on frequency ( Fig. 5e-i) , indicating that Arc decreases the number of functional AMPARs at synapses without significantly changing synapse number, similar to in previous findings 22 . In agreement with our findings on surface GluA1 expression, versions of Arc that did not localize to the nucleus had significantly less effect on mEPSC amplitude ( Fig. 5f,g) . Some of the effects of Arc on mEPSCs and AMPAR expression remained, despite loss of Arc in the nucleus, probably because Arc also functions at the synapse to regulate synaptic strength 21, 22 .
Arc regulates synaptic strength through GluA1 transcription Arc expression decreases AMPAR surface expression in vitro 21, 22 and in vivo 20 . This was previously attributed to a role of Arc in AMPAR endocytosis, but Arc localization to the nucleus clearly contributes to this effect as well ( Fig. 5) . Arc also decreases total amounts of GluA1 (ref. 21) , which cannot be explained solely by effects of Arc on endocytosis. Arc must have unknown roles in regulating the production or clearance of GluA1, a function that we hypothesized might be mediated by Arc in the nucleus. To test this, we measured the total amounts of GluA1 and found that Arc expression decreased them, similar to what has been shown 21 . However, versions of Arc that do not localize to the nucleus did not decrease the total amount of GluA1 ( Fig. 6a-c) . Thus, Arc acts in the nucleus to regulate total amounts of GluA1.
Because GluA1 transcription occurs in the nucleus and GluA1 clearance presumably occurs in the cytoplasm, we hypothesized that Arc lowers the amount of GluA1 by suppressing its transcription. We used a GluA1-luciferase reporter gene in which luciferase expression is controlled by the regulatory regions of the GluA1 promoter 34 . Arc expression markedly decreased luciferase activity ( Fig. 6d,e ), indicating that Arc suppresses GluA1 transcription. This shows that Arc regulates GluA1 production and is consistent with the immunocytochemistry findings of reduced total amounts of GluA1 in neurons that express Arc.
From these results, we could not tell whether Arc regulates GluA1 transcription by affecting activity-dependent signaling pathways emanating from the synapse or at the level of the GluA1 promoter. The actions of Arc on AMPAR endocytosis in the cytoplasm decrease If so, versions of Arc that stay in the cytoplasm should suppress GluA1-luciferase at least as potently as wild-type Arc. Instead, we found that preventing Arc from localizing to the nucleus blocked Arc suppression of GluA1-luciferase expression ( Fig. 6d,e ). We conclude that Arc in the nucleus decreases GluA1 transcription, thus decreasing the amounts of GluA1 protein and decreasing synaptic strength. GluA1 transcription can be regulated through cyclic AMP response elements (CREs) within its promoter 34 . We found that Arc expression in the nucleus suppresses the expression of a minimal CRE reporter gene ( Fig. 6f,g) . Arc also regulates another CRE-dependent gene, c-Fos, but does not seem to regulate the transcription or amounts of another AMPAR subunit, GluA2 (Supplementary Fig. 6a-e ), which lacks known CRE sites, indicating that Arc may regulate GluA1 transcription through its CRE sites. To test this, we mutated the four CRE sites in the GluA1 promoter of the GluA1-luciferase construct and found that Arc no longer decreased GluA1-luciferase expression ( Fig. 6h) . We then examined whether Arc can regulate endogenous GluA1 when its ability to control CRE-mediated transcription is removed. We expressed a constitutively active form of CREB (CREB-VP16) and Arc in neurons and measured surface GluA1 expression. CREB-VP16 expression blocked the Arc-dependent decrease in GluA1 expression ( Supplementary Fig. 6f) , demonstrating that Arc regulates GluA1 expression by decreasing CRE-mediated transcription.
Arc decreases GluA1 transcription through PML-NBs
Although Arc strongly suppresses GluA1 transcription, it has no known DNA binding regions. However, in HEK293 cells, Arc overexpression promotes the formation of PML-NBs 19 , which are nuclear structures that mediate a range of functions, including transcriptional regulation. Notably, GluA1 transcription can be regulated through CRE sites within its promoter 34 , and PML-NBs regulate CRE-dependent transcription in other cell types 35 . However, whether PML-NBs link to endogenous Arc or serve a crucial function in neurons is unknown.
To determine whether endogenous Arc upregulates PML, we stimulated neurons with BDNF. Arc induction correlated highly to PML expression in individual neurons (Fig. 7a,b) . In addition, sustained BDNF or bicuculline treatment often results in the formation of Arc nuclear puncta, which colocalize with PML, whereas sustained periods of decreased activity result in fewer Arc puncta ( Supplementary  Fig. 7a-c) . Arc coimmunoprecipitates with PML and CBP (Fig. 7c) , and BDNF increased PML expression at the same time points that Arc localized to the nucleus (Fig. 7d,e ). Stimulating synaptic activity with bicuculline also increased PML expression ( Supplementary  Fig. 7d,e ). To determine whether Arc is required for PML upregulation, we repeated the experiments in cultured neurons from wildtype and Arc −/− mice. Wild-type neurons showed a time-dependent increase in PML expression after BDNF treatment, but Arc −/− neurons did not ( Fig. 7f-i) . To determine whether increased amounts of PML protein resulted in increased PML-NB formation, we tracked neurons expressing enhanced GFP (eGFP)-tagged PML (eGFP-PML) over time with a robotic microscope 36 . BDNF treatment resulted in a robust increase in the formation of PML-NBs ( Fig. 7j and Supplementary  Fig. 7f ). Our data show that Arc mediates activity-induced PML-NB formation and characterize PML regulation in mature neurons.
We next determined whether PML is responsible for the effects of Arc on transcription. If Arc promotes the formation of PML-NBs and these structures are responsible for the effects of Arc on GluA1 expression, then increasing PML should phenocopy the effects of increased Arc on GluA1. Ectopic PML expression decreased surface and total GluA1 expression and GluA1-luciferase activity (Fig. 7k,l and Supplementary  Fig. 7g-i) , similarly to Arc expression in the nucleus. We conclude that PML is sufficient to decrease GluA1 expression. We then determined whether PML-NBs are necessary for Arc regulation of GluA1 by disrupting PML-NB function with the cytomegalovirus immediate-early gene 1 (IE1) 37 (Supplementary Fig. 7j ). We expressed IE1 or an inactive version of IE1 (IE1 ∆290-320 ) with Arc and measured total GluA1 protein. In neurons with disrupted PML-NBs, Arc no longer decreased total GluA1 expression ( Fig. 7m) . Another viral protein, ICP0, that works through a a r t I C l e S different mechanism to disrupt PML-NBs 38 had the same effect ( Fig. 7n and Supplementary Fig. 7k ). Thus, PML is both sufficient and necessary to mediate Arc suppression of total GluA1 protein expression.
Arc nuclear localization regulates homeostatic plasticity
We showed that prolonged periods of increased activity result in accumulation of Arc in the nucleus, which reduces synaptic strength globally by decreasing GluA1 transcription. Such a negative feedback mechanism to regulate activity encompasses the main elements of homeostatic synaptic scaling. In this form of plasticity, long periods of increased activity result in decreased synaptic strength, which allows neurons to maintain a stable firing rate. Arc is crucial for synaptic scaling in vitro and in vivo 5, 39 . We hypothesized that Arc functions in the nucleus to mediate synaptic scaling in response to increased activity. Bicuculline treatment, a known inducer of downscaling, significantly decreased surface GluA1 staining (Fig. 8a,b) . Ectopic expression of a version of Arc with normal nuclear localization (Arc-mNES) blocked the downscaling induced by bicuculline. Increased Arc expression in the nucleus presumably occluded downscaling by increasing the numbers of PML-NBs and decreasing GluA1 transcription and synaptic strength so they could not be lowered further by bicuculline. To confirm this, we tested the effects of a version of Arc that is excluded from the nucleus (Arc-NES) and found that it did not block downscaling (Fig. 8b) . Because the downscaling mechanism has not yet been activated in these neurons, bicuculline can do so by inducing endogenous Arc.
To ensure that these effects were not an artifact of overexpression, we developed an inducible form of Arc that is expressed in response to activity similarly to endogenous Arc and allows for the manipulation of Arc localization. Previous work elucidated the portions of the Arc promoter that are required to mediate activity-dependent Arc induction 9, 11 . We created constructs that used these regions (termed ABCDEFG for downstream regions and HI for upstream regions as described previously 9 ) to regulate Arc expression. To validate this approach, we put the Arc coding sequence under the control of these promoter regions and tagged Arc with a histidine (His)-Flag tag (ABCDEFG-Arc-His-Flag-HI) to allow for simultaneous staining of endogenous Arc and the tagged Arc in neighboring neurons. We then transfected this construct into rat neurons and induced Arc with BDNF. We quantified endogenous Arc induction using an Arc antibody and quantified ABCDEFG-Arc-His-Flag-HI induction with a Flag antibody. Endogenous Arc and ABCDEFG-Arc-His-Flag-HI had the same fold increase in expression in response to BDNF (Fig. 8c) , and ABCDEFG-Arc-His-Flag-HI had the same localization pattern in response to BDNF as endogenous Arc (Fig. 8d) . To allow for manipulation of Arc localization, we replaced the His-Flag tag with either the NES or mNES tag, which we described earlier in the text (Fig. 5c) . We transfected these constructs or a control plasmid into Arc −/− neurons. We induced scaling with bicuculline and found that Arc −/− neurons transfected with the control plasmid did not undergo homeostatic downscaling of GluA1. However, ABCDEFG-Arc-mNES-HI, which has normal localization to the nucleus, rescued homeostatic scaling. ABCDEFG-Arc-NES-HI, which does not localize to the nucleus, did not (Fig. 8e,f) . In the absence of stimuli, both ABCDEFG-Arc-mNES and ABCDEFG-Arc-NES-HI resulted in a small, nonsignificant decrease in surface GluA1 expression. This is probably a result (m) Quantification of total GluA1 in neurons transfected with IE1 ∆290-320 , which does not disrupt PML-NBs, or IE1, which prevents PML-NB formation, along with control or Arc plasmids. n = 37 for IE1 ∆290-320 + control, n = 31 for IE1 ∆290-320 + Arc, n = 34 for IE1 + control, and n = 37 for IE1 + Arc from three independent cultures. (n) Quantification of total GluA1 in neurons transfected with GFP or GFP-ICP0 and either control or Arc plasmids showing that PML is required for the effects of Arcs on total GluA1 expression. n = 34 for GFP + control, n = 31 for GFP + Arc, n = 29 for GFP-ICPO + control, and n = 29 for GFP-ICPO + Arc from three independent cultures. The full blots are shown in Supplementary Figure 9 . *P < 0.05, ***P < 0.001 by ANOVA. NS, not significant. Error bars (e,g,i,m,n) show 95% confidence intervals. Scale bars (a,j-l), 10 µm. n numbers throughout the legend refer to the numbers of neurons. npg a r t I C l e S of the high amount of basal activity in Arc −/− cultures, which result in some Arc induction and subsequent endocytosis of GluA1 at the synapse. However, downscaling only occurs when Arc can localize to the nucleus. We conclude that Arc must act in the nucleus to regulate homeostatic plasticity, and the functions of Arc in dendrites and synapses are not sufficient for downscaling.
To further demonstrate that Arc regulates transcription in response to downscaling stimuli, we also examined GluA1 mRNA. We treated wild-type or Arc knockout mouse neurons with bicuculline for 24 h and used quantitative real-time polymerase chain reaction (PCR) to measure changes in mRNA levels. We found that wild-type mouse neurons had decreased GluA1 mRNA levels in response to bicuculline, whereas Arc knockout neurons did not ( Supplementary  Fig. 8a) . Another receptor subunit, GluN2A, did not show similar changes (Supplementary Fig. 8b) . We then examined GluA1 expression by western blot analysis to provide an additional measurement of total GluA1 expression. Total GluA1 was decreased after 48 h of bicuculline treatment in wild-type but not Arc knockout mouse neurons (Supplementary Fig. 8c,d) , demonstrating that Arc is required for the activity-induced decrease in GluA1 expression. Therefore, prolonged periods of increased activity lead to Arc accumulation in the nucleus, which triggers PML-NB formation, suppression of GluA1 transcription and downscaling of synaptic strength (Supplementary Fig. 8e) .
DISCUSSION
Here we demonstrate that Arc becomes enriched in neuronal nuclei after a new experience and in response to prolonged increased activity. Arc has multiple regions that govern its localization to nuclei, including a Pat7 NLS, an NES and an NRD, which regulate import, export and retention within the nucleus, respectively. Short periods of activity decrease, and long periods of activity increase, nuclear localization. In the nucleus, Arc regulates global GluA1 expression and thereby regulates synaptic strength. This occurs through the activity-dependent formation of PML-NBs, which suppress GluA1 transcription. Through this mechanism, Arc localization to the nucleus regulates activitydependent downscaling in homeostatic plasticity.
Regulating Arc localization
An early study noted Arc localization to the soma 40 , and a recent study reported that the expression of Arc can be higher in the nucleus than the cytoplasm 19 . However, the role and mechanism of regulation of nuclear Arc were not known. We found evidence that localization of Arc protein is regulated by activity, complementing the extensive literature showing that synaptic activity regulates the transcription, mRNA localization, translation and degradation of Arc. We know of no gene other than Arc that is so highly regulated by synaptic activity. The extent to which the CNS controls Arc expression spatially and temporally underscores its importance.
Other plasticity-related proteins reportedly shuttle in and out of the nucleus, but the bidirectional regulation of Arc nuclear localization by activity is unique. We speculate that this may couple the effects of Arc on transcription to the immediate needs of the neuron. After short periods of stimulation, such as those resulting in LTP, synapses undergo potentiation, which involves increased AMPAR expression. Having Arc in the nucleus during these shortterm stimulations inhibits GluA1 transcription, so Arc is exported from the nucleus. In cases where stimulation is prolonged and the npg a r t I C l e S neuron must reduce its overall excitability, downscaling is activated by importing Arc into the nucleus. The activity dependence of Arc localization may explain the different patterns we observed after novel environment stimulation in different hippocampal regions. Because these regions receive different activity patterns and inputs, it is not surprising that they have different time courses of Arc translocation to the nucleus.
We also found that the total number of neurons expressing Arc decreases after long periods of exposure to a novel environment. This fits with our model of the function of Arc in homeostatic scaling. After long periods of novel environment exposure, some aspects of the environment presumably begin to lose their novelty. Thus, many neurons will not be continually activated for the duration of the experiment and will eventually shut off Arc expression. The few neurons that are continually activated are also those that need to undergo downscaling and send Arc to the nucleus.
PML-NBs in neurons
PML regulates cell fate in the embryonic neocortex 26 , and Arc promotes the formation of PML-NBs by interacting with the nuclear matrix protein spectrin βIV (ref. 19 ). However, PML-NBs mediate multiple functions in different cell types (for example, mRNA export, protein degradation or transcription), and little was previously known about them in neurons. Elucidating the function of PML in mature neurons is of particular importance because PML-NBs are disrupted in multiple neurodegenerative diseases [27] [28] [29] [30] . We showed that PML is both necessary and sufficient for mediating the nuclear functions of Arc. In addition, we provide evidence that PML regulates transcription in neurons and that activity regulates PML-NBs.
PML-NBs regulate transcription through multiple mechanisms, including the availability of transcription factors and the activity of histone deacetylases 24, 25, 41 . PML-NBs probably regulate GluA1 through CREB-binding protein (CBP), which promotes CREdependent transcription. CBP is a well-established binding partner of PML, and PML may sequester and degrade CBP 35 . Arc-induced upregulation of PML-NBs may result in accumulation and degradation of CBP at PML-NBs. The availability of CBP would decline, thereby decreasing CRE-dependent transcription of multiple activity-regulated genes, including GluA1.
Arc in plasticity
Our data assign a nuclear function to Arc: homeostatic downscaling. Arc is crucial for synaptic scaling in vitro and in vivo. Our proposed mechanism parsimoniously explains how Arc might regulate global synaptic strength without requiring that Arc act at each synapse individually to mediate cell-wide downscaling through endocytosis. In addition, our mechanism generally fits well with what is known about synaptic downscaling. Multiple studies have found that in response to a stimulus that increases activity, both surface and total expression of AMPARs are decreased 23, 42 . The decrease in total amounts of AMPARs suggests that downscaling involves a mechanism that regulates the amount of protein available cell wide, possibly by changing the amounts of transcription. In addition, scaling occurs on a timescale similar to that of AMPAR protein turnover and is a process that requires the transcription and translation of new proteins 43, 44 . Downscaling in response to increased activity is a cell-autonomous process 44 . Our proposed mechanism does not exclude the possibility of synaptic mechanisms acting in concert with transcriptional regulation or models proposing that Arc contributes to synaptic downscaling through AMPAR endocytosis 22, 45 . Much of the previous research into mechanisms underlying scaling has focused on GluA2. Although most of this previous work examined upscaling rather then downscaling, which is mediated by different mechanisms, our data do not exclude the possibility that GluA2 is also required for downscaling.
A role for nuclear Arc might also explain how Arc mediates functions that seem opposed to one another, such as consolidating LTP and LTD while also regulating scaling [1] [2] [3] [4] [5] . Arc regulates AMPAR endocytosis, and this function of Arc is probably required for some forms of LTD 4 . Arc also regulates spine structure and number 20 and Notch signaling 46 , which may underlie its ability to regulate the late phase of LTP. Our data do not contradict these proposed functions for Arc. In fact, preventing Arc localization to the nucleus resulted in a partial but not full return to baseline expression of surface GluA1. This result is consistent with a function for Arc outside the nucleus, probably at the synapse regulating GluA1 endocytosis. However, if Arc is prevented from localizing to the nucleus, total GluA1 expression and GluA1-luciferase return nearly to baseline. These data indicate that Arc localization to the nucleus is fully responsible for its ability to decrease GluA1 transcription, whereas both a nuclear and a dendritic function contribute to the decrease in surface GluA1 expression.
Our data support a model in which the function of Arc depends on its location 47, 48 . With short periods of stimulation, Arc is localized predominately in the cytoplasm, where it regulates the spine cytoskeletal matrix or the endocytic machinery. With long periods of stimulation, such as those that result in downscaling, Arc localizes to the nucleus, where it regulates synaptic strength by acting through PML-NBs. The delay in activity-induced Arc localization to the nucleus may allow for a temporal separation of these functions. This suggests that Arc is a master regulator of memory, mediating different forms of synaptic plasticity such as LTP, LTD and homeostatic scaling as needed depending on the nature of the stimulation.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
ONLINE METhODS
Behavior and tissue preparation. We used 3-month-old male mice (C57BL/6 strain) kept on a light-dark cycle for novel environment testing. Mice were added in pairs to a large cage (45 cm × 25 cm × 20 cm) in a new room with new bedding, odors, food and multiple new objects during the light cycle. Mice were allowed to explore the cage for varying times and were then deeply anesthetized and perfused transcardially with saline. Hemibrains were drop-fixed in 4% phosphate-buffered paraformaldehyde at 4 °C for 48 h. Brains were then rinsed in PBS, transferred to 30% sucrose in PBS at 4 °C for 24 h and coronally sectioned (30 µm) with a sliding microtome. All experiments were approved by the Institutional Animal Care and Use Committee of the University of California, San Francisco. cell culture. Long Evans rat hippocampal or cortical cells were dissected and dissociated from day 20 embryos and cultured for 10-14 d before transfections and treatments. Hippocampal neurons were used for all experiments except for the luciferase assays, western blot analyses and quantitative real-time PCR experiments, in which larger numbers of neurons were required and cortical neurons were used. Constructs were typically transfected using the calcium phosphate method. Luciferase constructs were transfected with Lipofectamine 2000 (Invitrogen).
Mouse cortical cells were dissected at postnatal day 0 from either wild-type C57BL/6 strain mice (Charles River) or Arc-d2EGFP knock-in mice 49 , which contain d2EGFP, followed by a neo cassette inserted after the Arc ATG start codon.
Pharmacology. BDNF (100 ng ml −1 ) was from Amgen. U0126 (1 µM), U73122 (1 µM), edelfosine (10 µM), d-2-amino-5-phosphonovaleric acid (AP5) and bicuculline (10 µM) were from Tocris. AKTX (5 µM) and tetrodotoxin (1 µM) were from Calbiochem/EMD. Leptomycin B (20 ng ml −1 ) and PD0325901 (2 µM) were from Sigma. Rapamycin (0.13 µM) was from Cayman Chemical.
constructs. GW1-Arc 20 contains the rat coding sequence of Arc flanked by the rat 3′ and 5′ untranslated regions, followed by a poly(A) tail. GW1-Arc 20 was used to create Arc constructs. The Pat7 NLS was found using PSORT (http:// psort.hgc.jp/), a program for subcellular localization prediction based on protein sequences. Arc deletion constructs were made using the Strategene QuikChange Site-Directed Mutagenesis Kit. GFP-Arc includes GFP at the N terminus of Arc. Myc-tagged Arc constructs contain Myc on the N terminus of Arc cloned into the HindIII and Kpn1 sites of pGW1. Arc-NES and Arc-mNES constructs were made by adding a tag between the Age1 and Mfe1 sites on the C terminus.
GFP-β-gal has been previously described 50 . Regions of Arc were cloned in between the SacII and XbaI sites. The construct containing two regions of Arc had amino acids 29-78 cloned in between the Nhe1 and Afl1 sites. The NLS-NES-GFP construct has been previously described 51 . The coding sequence for Arc amino acids 29-78 was cloned into the construct between the Pst1 and BamH1 sites in place of the Rev NLS. The NES region of Arc was cloned in between the BamH1 and Age1 sites of a NES-GFP construct in place of the NES. The PML construct has been previously described 52 .
Immunohistochemistry and immunocytochemistry. For immunohistochemistry, microtome slices were permeabilized with 0.5% Triton X-100 in PBS for 30 min and blocked in PBS with 5% donkey serum and 0.1% Triton X-100 for 1 h. Slices were incubated in primary antibody or antisera for 2 d at 4 °C, washed and incubated in secondary antibody overnight at 4 °C.
For immunocytochemistry, cells were fixed in 4% paraformaldehyde with 4% sucrose, permeabilized with 0.1% Triton X-100 in PBS for 10 min and blocked in PBS with 2% donkey serum, 3% bovine serum albumin and 0.1% Triton X-100 for 1 h. For surface staining, primary antibody was applied to live cells for 30 min at 37 °C before fixation, cells were not permeabilized and detergent was omitted from the blocking step. For all other staining, cells were incubated in primary antibody overnight at 4 °C after blocking. Surface and total GluA1 staining were performed 30 h after transfection, which is the half-life of GluA1. Secondary antibodies were applied for 1 h at room temperature. For co-staining for surface GluA1 and Arc, cells were first stained for surface GluA1 as described and then permeabilized, blocked and stained for Arc.
The primary antibodies and antisera used were to: Myc (mouse, Cell Signaling, 2276, 1:2,000), Flag (mouse, Sigma, 1804, 1:1,000), PML (mouse, Sigma, 1:100), surface GluA1 (mouse, Millipore, MAB2263, 1:300), GluA2 (mouse, Chemicon, MAB397, 1:300) and total GluA1 (rabbit, Abcam, ab27688, 1:40). For Arc staining, the polyclonal rabbit antisera that was used has been described 20 , or in cases in which co-staining with antisera raised in rabbit was required (for surface and total GluA1), a commercial Arc antibody (mouse, Santa Cruz, sc-17839, 1:100) was used. All secondary antibodies were used at 1:250 (Jackson). luciferase assays. Cortical neurons were transfected with a luciferase construct, a SEAP construct, which is constitutively expressed, and a control construct or an Arc construct. At 12 h after transfection, 50 µl of medium was collected from each well, and a SEAP assay (Applied Biosystems) was performed to assess transfection efficiency. At 30 h after transfection, lysates were collected and assayed with a Luciferase Kit (Promega) and a luminometer (Thermo Electron). To control for transfection efficiency, luciferase activity was normalized by SEAP activity in each well. Each set of constructs was transfected in triplicate in each independent culture, and values were averaged to obtain one value for each replicate. In addition, a set of coverslips was transfected in parallel for all Arc constructs used and stained for Arc to ensure that neurons demonstrated normal Arc localization and similar amounts of Arc for each construct used. western blotting. Assays were performed between 12 and 14 d in vitro as described 8 . Band intensities were quantified with ImageJ. The primary antibodies or antisera used were to PML (mouse, Sigma, P6746, 1:1,000), Arc 20 (rabbit, in-house antibody, 1:5,000) and GAPDH (chicken, Millipore, AB132, 1:5,000). Secondary antibodies conjugated to horseradish peroxidase (1:5,000) were imaged by enhanced chemiluminescence (Amersham Bioscience).
coimmunoprecipitation. Neurons were lysed in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 and 0.1% SDS), incubated for 1.5 h with magnetic beads (Thermo Scientific) and blocked in 4% bovine serum albumin at 4 °C. Additional blocked beads were incubated with Arc antiserum or IgG for 30 min. Lysates were transferred to antibody-bound beads and incubated for 1 h at 4 °C. Beads were washed three times with 1% Triton X-100 and then boiled for 5 min in loading buffer to elute proteins. electrophysiology. Hippocampal neurons were transfected at 12-14 d in vitro, and eGFP-expressing cells were recorded at 2-4 d after transfection in voltage clamp mode. The external solution (pH 7.35, 235 mOsm) contained AP5 (100 µM), tetrodotoxin (1 µM) and gabazine (10 µM) to isolate AMPAR currents. Patch recording pipettes (3-6 MΩ) were filled with an internal solution (pH 7.2, 223 mOsm). Recordings were only used if at least 300 mEPSCs were obtained. Data from each day were normalized to the average amplitude from control-transfected neurons from that day.
The external solution was kept at 25 °C and contained 119 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.5 mM CaCl 2 , 10 mM 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES) and 15 mM glucose. The internal solution contained 120 mM K-gluconate, 6 M NaCl, 1 mM MgCl 2 , 10 mM HEPES and 0.2 mM ethylene glycol tetraacetic acid. Data were acquired with an Axon MultiClamp amplifier and Clampex acquisition software and filtered at 2 kHz. AxoGraph software was used to correct for series resistance post hoc and identify and measure the amplitude and frequency of mEPSCs. Data were discarded if the series resistance increased over 30 MΩ, if there was a change in series resistance >10% over the course of the recording or if the holding current increased above 100 pAmp. One-way ANOVA with Fisher's post hoc test was used to compare groups. microscopy and image processing. Images of fixed primary neurons were acquired with a LSM510 confocal microscope system (Zeiss) and a ×63 oil immersion lens (numerical aperture 1.4). Confocal microscope settings were kept the same for all scans in which protein expression was compared. The first ten transfected neurons or separate fields of view observed were imaged to ensure random image collection. To achieve blinded image collection, transfected neurons were chosen for imaging using only the transfection-marker fluorescence or the nuclear stain without examination of the channel of interest (such as Arc or GluA1). When neurons were counted for Arc expression or localization, slide labels were covered and only revealed after data collection. To measure nuclear and cytoplasmic Arc expression, ImageJ was used to measure the average intensity in a region within the nucleus, a region immediately outside of
